Supplementary Data from Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C
Authors:
- Andreas WeissAWAndreas Weiss
- Edwige LorthioisELEdwige Lorthiois
- Louise BarysLBLouise Barys
- Kim S. BeyerKBKim S. Beyer
- Claudio Bomio-ConfagliaCBClaudio Bomio-Confaglia
- Heather BurksHBHeather Burks
- Xueying ChenXCXueying Chen
- Xiaoming CuiXCXiaoming Cui
- Ruben de KanterRKRuben de Kanter
- Lekshmi DharmarajanLDLekshmi Dharmarajan
- Carmine FedeleCFCarmine Fedele
- Marc GerspacherMGMarc Gerspacher
Open Access
- 4 April 2023
- other
- Published by American Association for Cancer Research (AACR)